What is Eevia Health?
Eevia Health Plc, established in March 2017, specializes in extracting bioactive compounds from plant materials, primarily sourced from wild-harvested flora in the Finnish and Swedish forests near the Arctic Circle. These high-quality extracts are supplied as ingredients to dietary supplement and food brands worldwide. The company operates a modern, green-chemistry production facility in Finland, ensuring a short and environmentally conscious value chain. This approach facilitates competitive pricing and extreme transparency in its operations. Eevia Health is committed to 100% organic certification for its products, with a notable focus on ingredients like Elderberry extract, alongside wild-harvested bilberry, lingonberry, chaga mushroom, and pine bark. The company successfully listed its shares on Spotlight Stock Market in Sweden in June 2021.
How much funding has Eevia Health raised?
Eevia Health has raised a total of $788K across 1 funding round:
Debt
$788K
Debt (2022): $788K with participation from Exelity AB
Key Investors in Eevia Health
Exelity AB
Exelity AB is an entity that participated in Eevia Health's debt financing round. Further details on their investment focus are not publicly available.
What's next for Eevia Health?
With the recent major strategic investment, Eevia Health is poised to further scale its operations and enhance its market penetration. The company's focus on sustainable sourcing and organic certification aligns with global consumer trends favoring natural and eco-friendly products. Future growth is expected to be driven by expanding its B2B client base among global dietary supplement and food manufacturers, potentially through increased production capacity and broader ingredient offerings. The enterprise-level backing suggests a strategic push towards solidifying its position as a leading supplier of premium, sustainably sourced plant extracts in the competitive health and wellness market.
See full Eevia Health company page
